Physician
Optum Care Washington PLLC
Optum Care Washington PLLC was paid $19.52M by Medicaid between Jan 2018 and Dec 2024, across 219 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoOPTUM CARE WASHINGTON PLLC
EVERETT, WA 98201
EVERETT, WA 98201
33aNPI1831186766assigned 10/05/2005
33bProvider typeFamily Medicine Physician
28Total paid$19.52M
24GClaims454,799
24DCodes billed219
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Washington
Rank by total paid#11 of 347
Median peer was paid$53K
This provider vs. median369×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 61,812 | $2.81M | |
| 2019 | 53,168 | $2.48M | |
| 2020 | 37,817 | $1.66M | |
| 2021 | 76,609 | $3.05M | |
| 2022 | 95,718 | $4.04M | |
| 2023 | 74,301 | $3.04M | |
| 2024incomplete | 55,374 | $2.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 146,833 | 141,846 | $8.33M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 85,590 | 82,761 | $4.47M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5.5% | 1,407 | 1,239 | $1.07M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.1% | 15,566 | 15,073 | $992K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.1% | 8,495 | 8,437 | $799K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.7% | 5,721 | 5,694 | $530K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.1% | 4,807 | 4,617 | $406K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 7,508 | 7,406 | $311K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.3% | 4,551 | 4,209 | $261K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 10,619 | 6,965 | $216K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 4,672 | 3,950 | $205K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 2,170 | 2,136 | $152K |
207 more codes
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 3,521 | $129K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,138 | $128K |
| J9271 | Injection, pembrolizumab, 1 mg | <1% | 16 | $112K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,069 | $107K |
| 90686 | <1% | 5,930 | $91K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,535 | $79K |
| 36415 | Collection of venous blood by venipuncture | <1% | 31,175 | $75K |
| 64615 | <1% | 1,179 | $71K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 812 | $64K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 912 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,155 | $43K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,176 | $42K |
| 80053 | Comprehensive metabolic panel | <1% | 7,249 | $41K |
| 99493 | <1% | 270 | $35K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 550 | $33K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 10,731 | $32K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 573 | $31K |
| 90674 | <1% | 1,215 | $28K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,114 | $27K |
| 90670 | <1% | 1,968 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 658 | $25K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 573 | $24K |
| 96367 | <1% | 1,653 | $23K | |
| 90688 | <1% | 1,920 | $22K | |
| 73630 | <1% | 1,519 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 487 | $20K |
| 92567 | <1% | 2,931 | $19K | |
| 59025 | Fetal non-stress test | <1% | 669 | $17K |
| 80061 | Lipid panel | <1% | 2,071 | $14K |
| 0012A | <1% | 359 | $12K | |
| 92557 | <1% | 825 | $12K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 613 | $12K |
| 92134 | <1% | 1,825 | $11K | |
| 0011A | <1% | 354 | $10K | |
| 90698 | <1% | 711 | $10K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 5,977 | $10K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 399 | $9K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 389 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,643 | $8K |
| 0071A | <1% | 227 | $8K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 692 | $8K |
| 11721 | <1% | 1,331 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 865 | $7K |
| 0001A | <1% | 195 | $7K | |
| 0072A | <1% | 182 | $7K | |
| 80050 | General health panel | <1% | 238 | $7K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 64 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,635 | $6K |
| 0002A | <1% | 159 | $6K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 869 | $6K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 407 | $6K |
| 90680 | <1% | 367 | $5K | |
| 0064A | <1% | 216 | $5K | |
| 0003A | <1% | 169 | $5K | |
| 96900 | <1% | 572 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 120 | $5K |
| 95117 | <1% | 694 | $4K | |
| 99243 | <1% | 51 | $4K | |
| 83970 | <1% | 347 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 108 | $3K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 471 | $3K |
| 90656 | <1% | 303 | $3K | |
| 95886 | <1% | 68 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 53 | $3K |
| 97161 | <1% | 71 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 59 | $3K |
| 85027 | <1% | 929 | $3K | |
| 99494 | <1% | 29 | $3K | |
| 92201 | <1% | 851 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 93 | $3K |
| 93971 | <1% | 51 | $2K | |
| 90633 | <1% | 204 | $2K | |
| 86140 | <1% | 808 | $2K | |
| 90677 | <1% | 131 | $2K | |
| 92083 | <1% | 153 | $2K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 564 | $2K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 94 | $2K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 18 | $2K |
| 92551 | <1% | 325 | $2K | |
| 90685 | <1% | 141 | $2K | |
| 92226 | <1% | 521 | $2K | |
| 84439 | <1% | 317 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 244 | $2K |
| D0120 | Dental checkup, returning patient | <1% | 101 | $2K |
| 96127 | <1% | 215 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $2K |
| 90480 | <1% | 50 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 15 | $2K |
| 90744 | <1% | 125 | $2K | |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 89 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 18 | $2K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 27 | $2K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 224 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 224 | $1K |
| 74018 | <1% | 95 | $1K | |
| 90651 | <1% | 107 | $1K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 92 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 286 | $1K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 40 | $1K |
| 99242 | <1% | 25 | $1K | |
| 73610 | <1% | 77 | $1K | |
| 86780 | <1% | 112 | $1K | |
| 92133 | <1% | 141 | $1K | |
| 73110 | <1% | 55 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 51 | $1K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 31 | $956.95 |
| 94729 | <1% | 66 | $945.67 | |
| 86803 | <1% | 72 | $913.84 | |
| 80069 | <1% | 455 | $908.94 | |
| 82728 | <1% | 166 | $893.40 | |
| 20610 | <1% | 61 | $849.68 | |
| 82570 | <1% | 557 | $841.87 | |
| 93015 | <1% | 45 | $839.37 | |
| 77080 | <1% | 136 | $812.85 | |
| 73140 | <1% | 39 | $772.15 | |
| 81513 | <1% | 13 | $743.32 | |
| 31575 | <1% | 14 | $733.17 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 936 | $731.32 |
| 73030 | <1% | 62 | $725.97 | |
| 85651 | <1% | 284 | $721.61 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 15 | $710.50 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $709.28 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 31 | $695.20 |
| 84466 | <1% | 127 | $676.45 | |
| 94010 | <1% | 91 | $667.95 | |
| 83735 | <1% | 266 | $650.37 | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $630.14 |
| 92579 | <1% | 25 | $630.04 | |
| 94760 | <1% | 3,459 | $620.38 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 24 | $586.32 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 52 | $566.50 |
| 95115 | <1% | 110 | $530.40 | |
| 94727 | <1% | 53 | $525.43 | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $516.98 |
| 99417 | Prolong home eval add 15m | <1% | 12 | $502.60 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $494.27 |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 17 | $474.43 |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $459.24 |
| 29125 | <1% | 18 | $448.75 | |
| 43235 | <1% | 12 | $441.59 | |
| 71250 | <1% | 13 | $436.19 | |
| 87653 | <1% | 12 | $419.04 | |
| 73130 | <1% | 29 | $412.39 | |
| 94060 | <1% | 41 | $394.75 | |
| 93296 | <1% | 158 | $379.83 | |
| 87481 | <1% | 26 | $379.20 | |
| 84156 | <1% | 382 | $375.65 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 18 | $371.36 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 26 | $364.83 |
| 83540 | <1% | 140 | $360.04 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 66 | $359.53 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $356.18 |
| 81001 | <1% | 265 | $352.45 | |
| 99499 | <1% | 12 | $341.17 | |
| 99421 | <1% | 45 | $338.67 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 25 | $338.25 |
| 82043 | <1% | 151 | $336.25 | |
| 99429 | <1% | 12 | $319.40 | |
| 84100 | <1% | 165 | $314.18 | |
| 92587 | <1% | 26 | $306.70 | |
| 1036F | <1% | 8,067 | $284.74 | |
| 90734 | <1% | 31 | $283.03 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $264.72 |
| 73502 | <1% | 14 | $241.89 | |
| 72100 | <1% | 13 | $241.19 | |
| 82607 | <1% | 51 | $227.79 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 53 | $208.87 |
| 84550 | <1% | 153 | $199.02 | |
| 73564 | <1% | 13 | $197.96 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $189.60 |
| 36591 | <1% | 13 | $186.16 | |
| 92504 | <1% | 14 | $175.70 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 108 | $166.90 |
| 87808 | <1% | 12 | $148.83 | |
| 93294 | <1% | 40 | $112.46 | |
| 69210 | <1% | 12 | $102.21 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 24 | $91.31 |
| 81002 | <1% | 44 | $80.64 | |
| 87081 | <1% | 12 | $72.49 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 52 | $71.78 |
| 90715 | <1% | 12 | $71.52 | |
| 80076 | <1% | 13 | $65.12 | |
| 85652 | <1% | 44 | $62.88 | |
| 85014 | <1% | 36 | $55.42 | |
| 85018 | <1% | 36 | $55.42 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 204 | $53.04 |
| 87210 | <1% | 12 | $53.02 | |
| 99490 | Ccm add 20min | <1% | 13 | $49.03 |
| 92136 | <1% | 27 | $45.36 | |
| A4649 | Surgical supply; miscellaneous | <1% | 53 | $22.90 |
| 82947 | <1% | 12 | $11.73 | |
| G0008 | Administration of influenza virus vaccine | <1% | 79 | $4.29 |
| 1160F | 0% | 2,169 | $0.00 | |
| 1159F | 0% | 2,873 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,194 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 953 | $0.00 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility | 0% | 72 | $0.00 |
| 90682 | 0% | 38 | $0.00 | |
| 3288F | 0% | 28 | $0.00 | |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 0% | 28 | $0.00 |
| 1158F | 0% | 14 | $0.00 | |
| 1170F | 0% | 41 | $0.00 | |
| 1111F | 0% | 54 | $0.00 | |
| 1157F | 0% | 13 | $0.00 | |
| 36000 | 0% | 56 | $0.00 | |
| 1125F | 0% | 34 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGO, GEORGE (BOARD PRESIDENT)
Parent organizationEVERETT PHYSICIANS, INC. P.S.
| Provider | Location | Paid |
|---|---|---|
| Optum Care Washington PLLC | Everett, WA | $937K |
| Optum Care Washington PLLC | Edmonds, WA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.